Due to current HHS restructuring, the information provided on aspe.hhs.gov is not being updated currently. Please refer to hhs.gov for more information.
An official website of the United States government
Here’s how you know
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The President has proposed, and at least one bill has been introduced in Congress, to change federal law that prevents health insurance from being offered nationally as opposed to in only state-specific markets.
With 45.7 million uninsured American in 2007, up from 38.4 million in 2000 (U.S. Census Bureau, 2008), health care reform is taking center stage as one of the top priorities for governors, state legislatures, and Congress.
Although the vast majority of privately insured people in the U.S. obtain their coverage in the employment-based group market, about 17 million people under age 65 were insured in the individual health insurance market in 2006. About 47 million people, or 16% of the total U.S. population, were without health insurance coverage in 2006.
Prepared by: The Lewin Group, Inc. Staff contributing to this project included Clifford Goodman, Charlene Chen, Lindsey Wu, Christel Villarivera, and Erin Karnes Prepared for: Office of the Assistant Secretary for Planning and Evaluation (ASPE)
This report presents the findings from an evaluation of the effect of health care cost growth on the U.S. economy. The evaluation consisted of 1) a thorough and systematic review of the existing literature, anecdotal evidence and survey findings, and 2) limited quantitative analyses of available secondary data sources.
Contents IGIV Supply and Distribution - Key Findings IGIV Demand - Key Fundings IGIV Access Problems- Key Fundings Immune globulin intravenous (IGIV), also referred to as intravenous immune globulin (IVIG), is a valuable treatment for many seriously ill patients. Although the U.S.
Some states have implemented community rating regulations to limit the extent to which premiums in the individual health insurance market can vary with a person's health status.
Contents Purpose and Methods Findings Strategies Related to Obtaining Information About Grant Opportunities, Deciding to Apply, and Preparing Grant Applications Strategies for Grant Review Processes
This report describes the effects of Cash and Counseling on the caregivers who were providing the most unpaid assistance to adult beneficiaries when those beneficiaries volunteered to participate in the demonstration and completed a baseline telephone interveiw.